Small Cap📈 ASX: BOT
Botanix Pharmaceuticals Limited (ASX:BOT)
Published 1 December 2025Penny Stock Spotlight Report
Botanix Pharmaceuticals Limited
(ASX: BOT)
Botanix Pharmaceuticals Ltd. is a dermatology-focused company involved in the research and development of skin and antimicrobial treatments. It operates across Australia and the United States. Founded in 1984 by Matthew Callahan, Roger New, and Glen Travers, the company is headquartered in West Perth, Australia.
Stock Performance Profile:
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Penny Stock Spotlight Report
A$399.00
Already a subscriber?
Sign in to read this report.
Required subscription
Penny Stock Spotlight Report
Explore emerging ASX penny stock opportunities through weekly research focused on early-stage companies, growth catalysts, and high-risk, high-potential investment ideas.
- ✓ Exclusive Weekly Penny Stock Research
- ✓ Delivered Every Monday
- ✓ Risk Rating: High Risk, High Reward
- ✓ Full Historical Report Access
A$399.00A$1500.00/ 12 months
Risk:High
Subscribe Now →
